The objective of this study was to evaluate donepezil, an acetylcholinesterase inhibitor, in the treatment of frontotemporal dementia (FTD).

In practice, patients with FTD use cholinesterase inhibitors – mainly donepezil – frequently [1]. At least in part, this may reflect diagnostic uncertainty, ...

The objective of this study was to evaluate donepezil, an acetylcholinesterase inhibitor, in the treatment of frontotemporal dementia (FTD).

Objective: The objective of this study was to evaluate donepezil, an acetylcholinesterase inhibitor, in the treatment of frontotemporal dementia (FTD).

These drugs, known as cholinesterase inhibitors (for example, donepezil, rivastigmine, galantamine) can actually make the symptoms of FTD worse. However ...

This report found that disinhibition and compulsions worsened in a subgroup of patients with FTD treated with donepezil.

All three of our cases showed remarkable reduction in the repetitive behaviors after adding donepezil.

31 авг. 2021 г. · Cholinesterase inhibitors such as donepezil or rivastigmine, often the first medication for Alzheimer's disease patients, have been reported ...

1 июл. 2013 г. · The clinical diagnosis of frontotemporal dementia was corroborated by a pathological diagnosis of frontotemporal lobar degeneration lacking ...

21 февр. 2019 г. · Cholinesterase inhibitors, such as donepezil, do not alleviate but can even exacerbate behavioral disturbance in patients with FTD (89). This is ... Cognitive and Behavioral... · Applications of FTD...